Einecs No: 234-118-0 Standard: Enterprise Standard Other Anti Cancer Product: Tamoxifen Citrate, Clomiphene Citrate, Toremifene Citrate, Anastrozole, Raloxifene hydrochloride, Fulvestrant, Letrozole, Crotamiton Usage:Tamoxifen is a female hormone which can blocks the actions of estrogen,it is usually used for treat some types of breast cancer in men and women.| Tamoxifen Citrate | non-steroidal agent |
| Exemestane | an aromatase inhibitor |
| Anastrozole | used when using substantial amounts of aromatizing steroids |
| Stanozolol | Cutting Cycles |
| Toremifene Citrate | non-steroidal selective Estrogen receptor modulator |
| Drostanolone Propionate | Anabolic Steroid |
| Methenolone Enanthate | the protein hormone assimilation strong activity of the liver |
| 17-methyltestosterone | androgen and Albumen Assimilation steroids |
| Fluoxymesterone | can be used as pharmaceutical material |
| Formestan | Used as an aromatic enzyme inhibitor |
| Breast Cancer | 10 to 20 mg orally twice daily |
| For metastatic breast cancer | 20 to 40 mg given in divided |
| Women with Ductal Carcinoma | 20 mg daily for 5 years |
| Reduce the incidence of breast cancer | 20mg daily for 5 years |
| Node-positive breast cancer,axillary dissection | 10 mg orally 2 to 3 times daily for 5 years. |
| Girls age 2 to 10 years with McCune-Albright Syndrome | 20 mg daily for one year |
| Tamoxifen citrate | Approved to prevent: Breast cancer in women who are at high risk for the disease. |
| Breast cancer in women and men | |
| being studied in the treatment of other types of cancer. |